Personal EKG maker AliveCor is seeking to ban sales of Apple watches in the United States after claiming the tech giant infringed its patented technology.
The company announced this week that it has filed a complaint with the US International Trade Commission alleging that Apple violated patent laws on three of AliveCor’s patented devices.
AliveCor claims that Apple knowingly copied its patented technology with the aim of crushing it as a competitor in the market.
Filing the complaint “is one step, among others, that AliveCor is taking to seek relief for Apple’s intentional copy of AliveCor’s patented technology – including the ability to take an ECG reading on it. Apple Watch and to perform heart rate analysis – as well as that of Apple’s efforts to eliminate AliveCor as a competitor in the heart rate analysis market for the Apple Watch, “the company said. in a press release.
WHAT IS THE IMPACT?
Last December, AliveCor filed a lawsuit against Apple, alleging violations of similar patents. The lawsuit argues that the tools included in the Apple Watch Series 4 and later infringe three patents owned by AliveCor.
In addition to Apple putting an end to the alleged infringement, AliveCor sought payment of damages from its company for its attorney fees and other costs associated with the lawsuit.
AliveCor offers a range of mobile ECG devices for personal use. Its flagship product, KardiaMobile, is a single-lead personal ECG. It launched the KardiaBand in 2017 as a complementary accessory to Apple Watch bands, but ceased sales shortly after Apple’s ECG capabilities went live.
Most recently, AliveCor received FDA clearance for the KardiaMobile 6L, a six-lead personal ECG that gives cardiologists six different perspectives on the electrical activity of the heart. It has also launched a subscription service, called KardiaCare, where members have access to a suite of features that help users interpret their heart data, monitor risk factors, identify symptom triggers, and measure blood pressure. impact of lifestyle changes.
Earlier this year, the company added three new heart conditions that its product line can identify, including sinus rhythm with supraventricular ectopia (EVS), sinus rhythm with premature ventricular contractions (PVC), and sinus rhythm with wide QRS.
THE BIGGEST TREND
Apple has faced several patent infringement lawsuits in the past. In 2016, heart rate sensor company Valencell sued Apple and Fitbit. The company alleged that Apple stole the technology that powered the Apple Watch’s heart rate sensor, obtaining the technology through insincere partnership openings and white papers uploaded under fake names.
Then in 2018, Omni MedSci took legal action against the tech giant for violating its heart rate monitoring technology.
In addition to the Apple Watch, more and more consumer clothing companies are adding ECG functionality to their devices. Fitbit’s ECG app got regulatory clearance in the US and EU last fall, and Samsung updated its Galaxy smartwatches with the capabilities earlier this year.